Meningitis, meningoencephalitis and encephalitis in Bern: an observational study of 258 patients.
Encephalitis
Meningitis
Meningoencephalitis
Sleep-wake disturbances
Tick-borne encephalitis
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
06 Dec 2021
06 Dec 2021
Historique:
received:
19
04
2021
accepted:
25
11
2021
entrez:
7
12
2021
pubmed:
8
12
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Depending on geographic location, causes of encephalitis, meningoencephalitis and meningitis vary substantially. We aimed to identify the most frequent causes, clinical presentation and long-term outcome of encephalitis, meningoencephalitis and meningitis cases treated in the Inselspital University Hospital Bern, Switzerland. In this monocentric, observational study, we performed a retrospective review of clinical patient records for all patients treated within a 3-year period. Patients were contacted for a telephone follow-up interview and to fill out questionnaires, especially related to disturbances of sleep and wakefulness. We included 258 patients with the following conditions: encephalitis (18%), nonbacterial meningoencephalitis (42%), nonbacterial meningitis (27%) and bacterial meningoencephalitis/meningitis (13%). Herpes simplex virus (HSV) was the most common cause of encephalitis (18%); tick-borne encephalitis virus (TBEV) was the most common cause of nonbacterial meningoencephalitis (46%), enterovirus was the most common cause of nonbacterial meningitis (21%) and Streptococcus pneumoniae was the most common cause of bacterial meningoencephalitis/meningitis (49%). Overall, 35% patients remained without a known cause. After a median time of 16 months, 162 patients participated in the follow-up interview; 56% reported suffering from neurological long-term sequelae such as fatigue and/or excessive daytime sleepiness (34%), cognitive impairment and memory deficits (22%), headache (14%) and epileptic seizures (11%). In the Bern region, Switzerland, TBEV was the overall most frequently detected infectious cause, with a clinical manifestation of meningoencephalitis in the majority of cases. Long-term neurological sequelae, most importantly cognitive impairment, fatigue and headache, were frequently self-reported not only in encephalitis and meningoencephalitis survivors but also in viral meningitis survivors up to 40 months after acute infection.
Sections du résumé
BACKGROUND
BACKGROUND
Depending on geographic location, causes of encephalitis, meningoencephalitis and meningitis vary substantially. We aimed to identify the most frequent causes, clinical presentation and long-term outcome of encephalitis, meningoencephalitis and meningitis cases treated in the Inselspital University Hospital Bern, Switzerland.
METHODS
METHODS
In this monocentric, observational study, we performed a retrospective review of clinical patient records for all patients treated within a 3-year period. Patients were contacted for a telephone follow-up interview and to fill out questionnaires, especially related to disturbances of sleep and wakefulness.
RESULTS
RESULTS
We included 258 patients with the following conditions: encephalitis (18%), nonbacterial meningoencephalitis (42%), nonbacterial meningitis (27%) and bacterial meningoencephalitis/meningitis (13%). Herpes simplex virus (HSV) was the most common cause of encephalitis (18%); tick-borne encephalitis virus (TBEV) was the most common cause of nonbacterial meningoencephalitis (46%), enterovirus was the most common cause of nonbacterial meningitis (21%) and Streptococcus pneumoniae was the most common cause of bacterial meningoencephalitis/meningitis (49%). Overall, 35% patients remained without a known cause. After a median time of 16 months, 162 patients participated in the follow-up interview; 56% reported suffering from neurological long-term sequelae such as fatigue and/or excessive daytime sleepiness (34%), cognitive impairment and memory deficits (22%), headache (14%) and epileptic seizures (11%).
CONCLUSIONS
CONCLUSIONS
In the Bern region, Switzerland, TBEV was the overall most frequently detected infectious cause, with a clinical manifestation of meningoencephalitis in the majority of cases. Long-term neurological sequelae, most importantly cognitive impairment, fatigue and headache, were frequently self-reported not only in encephalitis and meningoencephalitis survivors but also in viral meningitis survivors up to 40 months after acute infection.
Identifiants
pubmed: 34872509
doi: 10.1186/s12883-021-02502-3
pii: 10.1186/s12883-021-02502-3
pmc: PMC8647376
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
474Informations de copyright
© 2021. The Author(s).
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Neurology. 2006 Jan 10;66(1):75-80
pubmed: 16401850
PLoS One. 2021 Feb 8;16(2):e0246767
pubmed: 33556106
J Neuroimmunol. 2017 Nov 15;312:8-14
pubmed: 28889962
Lancet Infect Dis. 2018 Sep;18(9):992-1003
pubmed: 30153934
Clin Microbiol Infect. 2016 May;22 Suppl 3:S37-62
pubmed: 27062097
Ticks Tick Borne Dis. 2018 Feb;9(2):369-378
pubmed: 29275872
Clin Microbiol Infect. 2020 Sep;26(9):1192-1200
pubmed: 31927117
Clin Med (Lond). 2018 Mar;18(2):155-159
pubmed: 29626021
Eur J Neurol. 2012 Jan;19(1):62-8
pubmed: 21615626
Nervenarzt. 2007 Jun;78(6):651-6
pubmed: 16832698
Curr Opin Neurol. 2014 Jun;27(3):361-8
pubmed: 24792345
Brain. 1999 Nov;122 ( Pt 11):2067-78
pubmed: 10545392
Neurology. 2010 Sep 7;75(10):924-32
pubmed: 20820004
J Infect. 2018 Mar;76(3):225-240
pubmed: 29305150
Clin Infect Dis. 2003 Mar 15;36(6):731-42
pubmed: 12627357
Swiss Med Wkly. 2013 Jan 08;143:w13725
pubmed: 23299974
J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):554-8
pubmed: 16543543
Clin Infect Dis. 2009 Dec 15;49(12):1838-47
pubmed: 19929384
Sleep. 2008 Nov;31(11):1601-7
pubmed: 19014080
Brain. 2006 Feb;129(Pt 2):333-45
pubmed: 16364957
Acta Neurol Scand. 2016 Dec;134(6):434-441
pubmed: 26810689
N Engl J Med. 2019 Jun 13;380(24):2327-2340
pubmed: 31189036
Sleep Med. 2014 Aug;15(8):860-73
pubmed: 25023924
Front Immunol. 2018 Jun 08;9:1299
pubmed: 29951056
Respiration. 1999;66(5):440-7
pubmed: 10516541
Med Mal Infect. 2017 May;47(3):221-235
pubmed: 28341533
Lancet. 2019 Feb 16;393(10172):702-716
pubmed: 30782344
J Neurol. 2019 Sep;266(9):2137-2143
pubmed: 31127382
Clin Infect Dis. 2002 Sep 15;35(6):650-8
pubmed: 12203160
BMC Psychiatry. 2016 May 31;16:174
pubmed: 27245844
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
Sleep Med. 2001 Jul;2(4):297-307
pubmed: 11438246
Sleep. 1991 Dec;14(6):540-5
pubmed: 1798888
J Med Virol. 2013 Mar;85(3):554-62
pubmed: 23239485
Vaccine. 2020 Nov 17;38(49):7825-7833
pubmed: 33164805
Neurology. 2013 Aug 27;81(9):793-800
pubmed: 23892708
J Neurol. 2020 Jun;267(6):1802-1811
pubmed: 32140868
Eur J Neurol. 2017 Oct;24(10):1214-e61
pubmed: 28762591
J Neurol Neurosurg Psychiatry. 1996 May;60(5):504-9
pubmed: 8778253
Clin Infect Dis. 2012 May;54(10):1455-64
pubmed: 22460967
Lancet Infect Dis. 2010 Dec;10(12):835-44
pubmed: 20952256
Ann Neurol. 2018 Jan;83(1):166-177
pubmed: 29293273